PHARMA SOLUTIONS
ActiveSummary
PHARMA SOLUTIONS has been active since 1999 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €158,716 and a net result of €59,656. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 39% of 3,844 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
15-10
NBB filing
Annual accounts filed
financial year 2025 · full format · 76 days late
2025
31-12
Financial
Equity above €150,000equity €158,716 ▲60.2%
3 profitable years in a row build equity to €158,716.
29-09
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format · 60 days late
2024
31-12
Financial
Highest result from 2018 to 2025net €65,461 ▲152%
Net result €65,461, the highest in the series.
11-10
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format · 72 days late
2023
31-12
Financial
Back to profitnet €25,984
Net result €25,984 after one loss-making year.
04-12
Gazette deed
Resignations: Waelput Bart (director) and Foubert Marjan (director)Appointment: Waelput Bart (sole director) · Registered office clause · Board rule11 facts ▸
Gazette deed
Resignations: Waelput Bart (director) and Foubert Marjan (director)
Appointment: Waelput Bart (sole director) · Registered office clause · Board rule11 facts ▸
- Registered office clause, “9100 Sint-Niklaas Nieuwkerkenstraat 111, blijft behouden” (deed in Dutch)
- Other provision, “Wetboek van vennootschappen en verenigingen”, 01-01-2020 (deed in Dutch)
- Board rule, “Eerste besluit, enige bestuurder” (deed in Dutch)
- Director resignation, Waelput Bart (director)
- Director resignation, Foubert Marjan (director)
- Director discharge, Waelput Bart
- Director discharge, Foubert Marjan
- Other provision, “bekrachtiging verleden handelingen bestuurders, voor zover nodig” (deed in Dutch)
- Director appointment, Waelput Bart (sole director)
- Amendment of the articles
- Capital, €61,500
23-11
Gazette deed
Reappointment: Waelput Bart (director)2 facts ▸
Gazette deed
Reappointment: Waelput Bart (director)
2 facts ▸
- General meeting, 04-10-2023
- Director reappointment, Waelput Bart (director)
09-10
NBB filing
Annual accounts filed
financial year 2022 · abbreviated format · 70 days late
2022
21-12
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format · 143 days late
2021
16-12
NBB filing
Annual accounts filed
financial year 2020 · abbreviated format · 138 days late
2020
31-12
Financial
Back to profitnet €21,370
Net result €21,370 after 2 loss-making years.
Show earlier events
11-12
NBB filing
Annual accounts filed
financial year 2019 · abbreviated format · 133 days late
2019
31-12
Financial
Weakest financial yearnet -€13,373
Net result drops to -€13,373, the lowest in the series; recovery starts the following year.
30-12
NBB filing
Annual accounts filed
financial year 2018 · abbreviated format · 152 days late
2018
25-09
NBB filing
Annual accounts filed
financial year 2017 · abbreviated format · 56 days late
2017
10-02
NBB filing
Annual accounts filed
financial year 2016 · abbreviated format · 10 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 25 annual accounts filed, the latest 10 are here; all 25 are under Financials.
2 of 6 deeds read
About the unread acts
Of the 6 Belgian Official Gazette deeds we know for this company, 2 have been read. The other 4 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.